Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model

被引:27
|
作者
Beusterien, K.
Bell, J. A. [1 ]
Grinspan, J. [1 ]
Utset, T. O. [2 ]
Kan, H.
Narayanan, S.
机构
[1] Oxford Outcomes Inc, Patient Reported Outcomes, Oxford, MS USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
关键词
Systemic lupus erythematosus; patient-physician communications; patient satisfaction; QUALITY-OF-LIFE; DECISION-MAKING; COMMUNICATION; CARE; ILLNESS; PEOPLE; RACE;
D O I
10.1177/0961203313499958
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The objective was to develop a conceptual model illustrating the relationships between the physician-patient relationship and patient outcomes, including health status and regimen satisfaction, in systemic lupus erythematosus (SLE). Methods This was a cross-sectional survey of a geographically diverse sample of adults with SLE in the United States. Patients completed a Web-based survey that focused on physician interactions, clinical management, and patient outcomes, including patient perception of treatment regimen and health status. All survey variables related to physician interactions and patient perceptions of their health and satisfaction were evaluated for incorporation into a patient-centered model using cluster analysis. Structural equation modeling (SEM) was conducted to assess the inter-relationships observed among the variables to inform the development of a conceptual model of SLE patient-centered care. Results A total of 302 SLE patients completed the survey. The majority of patients were female (94.3%) with a mean age of 46 years. The cluster analysis resulted in six main factors: 1) physician interactions, 2) current health and hope, 3) satisfaction with treatment, 4) bedside manner, 5) discussion of lupus impacts during physician visits, and 6) steroid treatment. The significant relationships among the factors showed that positive physician interactions, such as including the patient in treatment decisions, were associated with higher satisfaction with treatment regimen and patients feeling that SLE was well controlled, a more favorable perception of current health, and being more hopeful about future health. Among the components of physician interactions, setting goals with patients is particularly important, as this was significantly associated with the patient being more hopeful about future health. Being steroid free was significantly related to higher treatment satisfaction. Conclusion The study findings informed a conceptual model of SLE patient-centered care that may be used to create more targeted education programs in the management of SLE, with the goal to improve patient outcomes.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 50 条
  • [21] Vasculitis and TTP/HUS in a patient with systemic lupus erythematosus (SLE).
    Silva, VA
    Gonzalez, E
    Hillyer, CD
    BLOOD, 1997, 90 (10) : 3109 - 3109
  • [22] Prevalence of oral manifestations in patient with Systemic Lupus Erythematosus (SLE)
    Zakeri, Zahra
    Narouie, Behzad
    Bakhshipour, Alireza
    Sarabadani, Javad
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (03): : 1307 - 1311
  • [23] Patient with systemic lupus erythematosus (SLE) and nocardial brain abscesses
    Bukovac, LT
    Jelusic, M
    Bozinovic, D
    Mise, B
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 538 - 538
  • [24] DEPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A DOMINICAN PATIENT COHORT
    Then, J.
    Loyo, E.
    Gotschalk, P.
    Vasquez, R.
    Franco, K.
    Tineo, C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S53 - S53
  • [25] EPILEPSY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Hopia, L.
    Andersson, M. L.
    Svenungsson, E.
    Piehl, F.
    Tomson, T.
    EPILEPSIA, 2014, 55 : 99 - 99
  • [26] Hypertrichosis in Systemic Lupus Erythematosus (SLE)
    M. Santiago
    A. C. Travassos
    M. C. Rocha
    S. Souza
    Clinical Rheumatology, 2000, 19 : 245 - 246
  • [27] Systemic lupus erythematosus and the SLE galaxy
    Meroni, P. L.
    Shoenfeld, Y.
    AUTOIMMUNITY REVIEWS, 2010, 10 (01) : 1 - 2
  • [28] Menopause and systemic lupus erythematosus (SLE)
    Huong, DLT
    Boddaert, J
    Andreu, MR
    Wechsler, B
    Amoura, Z
    Godeau, P
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S583 - S583
  • [29] Management of systemic lupus erythematosus (SLE)
    Morton, SJ
    Powell, RJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (05): : 686 - 693
  • [30] Hydroxychloroquine in systemic lupus erythematosus (SLE)
    Ponticelli, C.
    Moroni, G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 411 - 419